Add BrightSurf on Google Email

Science News for June 14, 2007


JCI table of contents: June 14, 2007

Researchers found that TRAIL limits inflammation and brain cell death in bacterial meningitis by regulating the host immune response. In contrast, mice lacking TRAIL exhibited increased inflammation and brain cell death, which was reversed by administering recombinant TRAIL.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 14, 2007

27-year wait for symptoms

A woman's symptoms of colitis emerged 27 years after she left the country where she was infected with a parasitic worm. Analysis revealed larvae of Strongyloides stercoralis caused her digestive issues, highlighting the importance of considering this rare disease in patients with cellular immune defects.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 14, 2007

Emulsion with a round-trip ticket

Researchers successfully create a double inversion of an emulsion by adding surfactant to a nanoparticle-containing mixture. The process, which uses silica nanoparticles and a specific type of surfactant, allows for the conversion between oil-in-water and water-in-oil emulsions.

SourceWiley·DateJun 14, 2007

Yale journal examines the global impact of cities

A special issue of Yale's Journal of Industrial Ecology explores the global impact of cities, showcasing their role in driving environmental changes. The study reveals that cities produce greenhouse gases with worldwide effects and stimulate resource extraction beyond city borders.

SourceYale University·JournalJournal of Industrial Ecology·DateJun 14, 2007

Preliminary results suggest Certolizumab Pegol is effective in reducing signs and symptoms

Preliminary results show that 59% of patients receiving certolizumab pegol 200mg plus methotrexate achieved a 20% improvement in symptoms after 24 weeks, compared to 14% for those taking methotrexate alone. The treatment combination also resulted in higher ACR70 responses and lower discontinuation rates due to adverse events.

Cytokine resistance contributes to pathology of type 2 diabetes

A new study from the University of Illinois found that cytokine resistance contributes to the pathology of type 2 diabetes by impairing the anti-inflammatory response and disrupting insulin-like signaling pathways. This impairment leads to chronic inflammation, which exacerbates health issues in individuals with obesity or diabetes.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalThe Journal of Immunology·DateJun 14, 2007

Australia weighs in to make the perfect kilogram

Australian scientists and optical engineers are working with the International Bureau of Weights and Measures to create a perfect sphere from a single crystal of exceptionally pure silicon. The goal is to redefine the kilogram, currently defined by a physical object in France, using a fundamental constant of nature.

University of Pittsburgh researchers culture blood-forming stem cells from human fat tissue

Researchers at the University of Pittsburgh successfully isolated and cultured human hematopoietic stem cells from fat tissue, suggesting an alternate source for life-saving bone marrow transplants. The study's findings indicate that these stem cells are integral to normal adipose tissue and may provide a safer alternative for patients...

Clocking in and out of gene expression

Researchers discovered that genes have internal clocks regulated by coactivators, controlling protein production and preventing cancerous growth. The coactivator's clock is set off through the addition of phosphate and ubiquitin molecules, with a fixed lifespan to prevent continuous activation.